GMAB

Genmab A Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↓ 4/10
  • Momentum↑ 6/10
Genmab A sales and earnings growth
GMAB Growth
Neutral
  • Revenue Y/Y↑ 19.19%
  • EPS Y/Y↓ -12.23%
  • FCF Y/Y↓ 4.53%
Genmab A gross and profit margin trends
GMAB Profitability
Great
  • Gross margin ↑ 93.60%
  • EPS margin↑ 25.90%
  • ROIC↑ 45.20%
Genmab A net debt vs free cash flow
GMAB Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 3.3
  • Interest coverage↑ 5.5

Genmab A stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗